These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 23898837)

  • 1. Old diseases and contemporary crisis. Inherited blood disorders in the Sultanate of Oman.
    Beaudevin C
    Anthropol Med; 2013; 20(2):175-89. PubMed ID: 23898837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Blood Disorders Survey in the Sultanate of Oman.
    Al-Riyami A; Ebrahim GJ
    J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should Premarital Screening for Blood Disorders be an Obligatory Measure in Oman?
    Al-Balushi AA; Al-Hinai B
    Sultan Qaboos Univ Med J; 2018 Feb; 18(1):e24-e29. PubMed ID: 29666677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A community-based study of common hereditary blood disorders in Oman.
    Al-Riyami AA; Suleiman AJ; Afifi M; Al-Lamki ZM; Daar S
    East Mediterr Health J; 2001 Nov; 7(6):1004-11. PubMed ID: 15332742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extended molecular spectrum of beta- and alpha-thalassemia in Oman.
    Hassan SM; Hamza N; Jaffer Al-Lawatiya F; Jaffer Mohammed A; Harteveld CL; Rajab A; Giordano PC
    Hemoglobin; 2010 Jan; 34(2):127-34. PubMed ID: 20353347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 'Rakter dosh'--corrupting blood: The challenges of preventing thalassemia in Bengal, India.
    Chattopadhyay S
    Soc Sci Med; 2006 Nov; 63(10):2661-73. PubMed ID: 16901596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repository of mutations from Oman: The entry point to a national mutation database.
    Rajab A; Hamza N; Al Harasi S; Al Lawati F; Gibbons U; Al Alawi I; Kobus K; Hassan S; Mahir G; Al Salmi Q; Mons B; Robinson P
    F1000Res; 2015; 4():891. PubMed ID: 26594346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 diabetes in the sultanate of Oman.
    Al-Shookri A; Khor GL; Chan YM; Loke SC; Al-Maskari M
    Malays J Nutr; 2011 Apr; 17(1):129-41. PubMed ID: 22135872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular heterogeneity of beta-thalassemia alleles in Spain and its importance in the diagnosis and prevention of beta-thalassemia major and sickle cell disorders.
    Pereira Mdel M; Dalmau AC; Corrons JL
    Hemoglobin; 2009; 33(3):226-34. PubMed ID: 19657837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hb A2' (Hb B2) in the Omani population and diagnostic significance.
    Daar S; Al Zadjali S; Gravell D; Al Haddabi H; Al Riyami M; Al Belushi A; Berbar T; Krishnamoorthy R
    Hemoglobin; 2011; 35(2):117-24. PubMed ID: 21417568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Congenital anemia].
    Graubner UB; Schmidt P; Haas RJ
    Internist (Berl); 1994 Mar; 35(3):269-74. PubMed ID: 8175291
    [No Abstract]   [Full Text] [Related]  

  • 12. [From gene to disease; from hemoglobin genes to thalassemia and sickle cell anemia].
    de Jong A; de Wert G
    Ned Tijdschr Geneeskd; 2000 Dec; 144(51):2480-1. PubMed ID: 11151663
    [No Abstract]   [Full Text] [Related]  

  • 13. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine profile of sickle cell disease in Oman.
    Pathare A; Al Kindi S; Alnaqdy AA; Daar S; Knox-Macaulay H; Dennison D
    Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Monitoring pregnant patients from risk countries with sickle cell disease and thalassemia. Clinical aspects, screening and prenatal diagnosis].
    Dickerhoff R; Kulozik AE; Kohne E
    Geburtshilfe Frauenheilkd; 1993 Apr; 53(4):215-21. PubMed ID: 8491363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates.
    Alkindi S; Al Zadjali S; Al Madhani A; Daar S; Al Haddabi H; Al Abri Q; Gravell D; Berbar T; Pravin S; Pathare A; Krishnamoorthy R
    Hemoglobin; 2010 Jan; 34(2):135-44. PubMed ID: 20353348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic services and testing in the Sultanate of Oman. Sultanate of Oman steps into modern genetics.
    Rajab A; Al Rashdi I; Al Salmi Q
    J Community Genet; 2013 Jul; 4(3):391-7. PubMed ID: 23821042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Race and social attitudes about sickle cell disease.
    Bediako SM; Moffitt KR
    Ethn Health; 2011; 16(4-5):423-9. PubMed ID: 21797727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation in Oman.
    Dennison D; Al Kindi S; Pathare A; Daar S; Nusrat N; Ur Rehman J; Zia F; Khan H; Khan MI; Alghazaly A; Al Zadjali S; Tauro M; Al Lawatia A; Ganguly S
    Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S109-S113. PubMed ID: 18724280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. University students in Nigeria: knowledge, attitude toward sickle cell disease, and genetic counseling before marriage.
    Moronkola OA; Fadairo RA
    Int Q Community Health Educ; 2006-2007; 26(1):85-93. PubMed ID: 17686716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.